Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Risa Kagan

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Menopause (New York, N.Y.)|April 6, 2016
Effects of ospemifene on bone parameters including clinical biomarkers in postmenopausal womenGinger D Constantine, Risa Kagan, Paul D Miller
Menopause (New York, N.Y.)|December 25, 2009
The effects of raloxifene on mammographic breast density: a review of clinical trialsLeny Pearman, Risa Kagan, Jody Arsenault, et al.
Menopause (New York, N.Y.)|September 1, 2021
Impact of sleep disturbances on employment and work productivity among midlife women in the US SWAN database: a brief reportRisa Kagan, Aki Shiozawa, Andrew J Epstein, et al.
Menopause (New York, N.Y.)|December 27, 2018
Improvement in sleep outcomes with a 17β-estradiol-progesterone oral capsule (TX-001HR) for postmenopausal womenRisa Kagan, Ginger Constantine, Andrew M Kaunitz, et al.
Menopause (New York, N.Y.)|March 11, 2008
Bone turnover marker profile in relation to the menstrual cycle of premenopausal healthy womenMargery L Gass, Risa Kagan, Joseph D Kohles, et al.
Menopause (New York, N.Y.)|October 24, 2013
Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopauseJoAnn V Pinkerton, Risa Kagan, David Portman, et al.
Therapeutics and Clinical Risk Management|April 23, 2016
Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifeneRisa Kagan, Steven R Goldstein, James H Pickar, et al.
Menopause (New York, N.Y.)|September 26, 2009
A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal womenRisa Kagan, R Stan Williams, Kaijie Pan, et al.
Fertility and Sterility|July 29, 2009
Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal womenRobert Lindsay, J Christopher Gallagher, Risa Kagan, et al.
Menopause (New York, N.Y.)|February 25, 2022
Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptomsMichael R McClung, Risa Kagan, Shelli Graham, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Menopause (New York, N.Y.)|April 6, 2016
Effects of ospemifene on bone parameters including clinical biomarkers in postmenopausal womenGinger D Constantine, Risa Kagan, Paul D Miller
Menopause (New York, N.Y.)|December 25, 2009
The effects of raloxifene on mammographic breast density: a review of clinical trialsLeny Pearman, Risa Kagan, Jody Arsenault, et al.
Menopause (New York, N.Y.)|September 1, 2021
Impact of sleep disturbances on employment and work productivity among midlife women in the US SWAN database: a brief reportRisa Kagan, Aki Shiozawa, Andrew J Epstein, et al.
Menopause (New York, N.Y.)|December 27, 2018
Improvement in sleep outcomes with a 17β-estradiol-progesterone oral capsule (TX-001HR) for postmenopausal womenRisa Kagan, Ginger Constantine, Andrew M Kaunitz, et al.
Menopause (New York, N.Y.)|March 11, 2008
Bone turnover marker profile in relation to the menstrual cycle of premenopausal healthy womenMargery L Gass, Risa Kagan, Joseph D Kohles, et al.
Menopause (New York, N.Y.)|October 24, 2013
Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopauseJoAnn V Pinkerton, Risa Kagan, David Portman, et al.
Therapeutics and Clinical Risk Management|April 23, 2016
Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifeneRisa Kagan, Steven R Goldstein, James H Pickar, et al.
Menopause (New York, N.Y.)|September 26, 2009
A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal womenRisa Kagan, R Stan Williams, Kaijie Pan, et al.
Fertility and Sterility|July 29, 2009
Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal womenRobert Lindsay, J Christopher Gallagher, Risa Kagan, et al.
Menopause (New York, N.Y.)|February 25, 2022
Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptomsMichael R McClung, Risa Kagan, Shelli Graham, et al.
Pageof 5